title: A rebuttal to the potential anti-tumour benefit of Helicobacter pylori-induced neutrophil-activating protein.
authors: Jannis
authors: J
authors: Kountouras
authors: Christos
authors: C
authors: Zavos
authors: Emmanuel
authors: E
authors: Gavalas
authors: Georgia
authors: G
authors: Deretzi
authors: Afroditi
authors: A
authors: Tsona
authors: Panagiotis
authors: P
authors: Katsinelos
authors: Savas
authors: S
authors: Grigoriadis
authors: Ioannis
authors: I
authors: Pilpilidis
authors: Dimitrios
authors: D
authors: Tzilves
authors: Elizabeth
authors: E
authors: Vardaka
authors: Konstantinos
authors: K
authors: Mantzoukis
authors: Stergios A
authors: SA
authors: Polyzos
mesh_terms: D000818:Animals; D001500:BCG Vaccine / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000494:pharmacology*; D005260:Female; D016480:Helicobacter pylori / Q000276:immunology*; D006801:Humans; D018417:Th1 Cells / Q000276:immunology*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000276:immunology*
chemical_list: D001500:BCG Vaccine; D001426:Bacterial Proteins